Clay Brian Ritchey, Chief Executive Officer and Director of Definitive Healthcare Corp., filed a statement of changes in beneficial ownership on October 27, 2026, reporting the acquisition of 2,626,263 restricted stock units on October 23, 2026.

Key Highlights

  • Reporting person: Clay Brian Ritchey, serving as Chief Executive Officer and Director of Definitive Healthcare Corp.
  • Securities acquired: 2,626,263 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock, acquired at a price of $0.
  • Transaction date: October 23, 2026, with the filing submitted on October 27, 2026.
  • Vesting schedule: 25% of RSUs vest on September 8, 2027, followed by 6.25% every three months over the subsequent three years.
  • Resulting ownership: Ritchey directly holds 2,626,263 shares following the reported transaction.
  • Transaction code: "A" (acquisition), held directly, with no indirect beneficial ownership reported.

RSU Grant to CEO Ritchey: Structure and Context at Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ:DH) is a healthcare commercial intelligence company headquartered in Framingham, Massachusetts. The company's platform provides data, analytics, and insights on healthcare providers and organizations, serving customers that rely on its information to inform commercial strategy decisions in the healthcare sector.

According to the filing, Ritchey received 2,626,263 RSUs on October 23, 2026, at no cost to him. Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock, par value $0.001. The filing notes that the award is subject to a multi-year vesting schedule: 25% of the RSUs vest on September 8, 2027, followed by quarterly vesting of 6.25% of the total grant every three months over the three years after that date. Vesting in each case is contingent on Ritchey's continued service with the company through each applicable vesting date.

The filing was signed by Jonathan Paris as Attorney-in-Fact on October 27, 2026. No derivative securities were reported in Table II, and the transaction code recorded was "A," designating an acquisition. The RSUs are held directly by Ritchey, and no indirect beneficial ownership arrangements were disclosed in connection with this grant.

What Was Disclosed

The filing reported the acquisition of 2,626,263 RSUs by Definitive Healthcare's Chief Executive Officer, Clay Brian Ritchey, on October 23, 2026. Following the transaction, Ritchey directly holds 2,626,263 shares of Class A Common Stock on a beneficial basis.